OTCMKTS:NGSX - NeurogesX Stock Price, Price Target & More

$0.0050 0.00 (-28.57 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$0.0070
Today's Range$0.0037 - $0.0060
52-Week Range$0.0025 - $0.0150
Volume280,100 shs
Average Volume70,548 shs
Market Capitalization$129,628.00
P/E RatioN/A
Dividend YieldN/A
Beta-1.4

About NeurogesX (OTCMKTS:NGSX)

NeurogesX Inc. (NeurogesX), is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pains management therapies to address unmet medical needs. Qutenza is the Company's first commercial product, available in the United States and in certain European countries. Qutenza is a dermal delivery system designed to topically administer capsaicin to treat certain neuropathic pain conditions and was approved by the food and drugs administration (FDA) for the management of neuropathic pain associated with postherpetic neuralgia (PHN). Qutenza is also approved in the European Union for the treatment of peripheral neuropathic pain in non-diabetic adults. The Company's advanced drug candidate is NGX-1998. NGX-1998 is a topical liquid formulation of high concentration capsaicin that the Company is developing to treat neuropathic pain conditions.

Receive NGSX News and Ratings via Email

Sign-up to receive the latest news and ratings for NGSX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:NGSX
CUSIPN/A
Phone+1-650-3583300

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-134.62%
Return on EquityN/A
Return on Assets-68.56%

Miscellaneous

EmployeesN/A
Outstanding Shares33,330,000

How to Become a New Pot Stock Millionaire

NeurogesX (OTCMKTS:NGSX) Frequently Asked Questions

What is NeurogesX's stock symbol?

NeurogesX trades on the OTCMKTS under the ticker symbol "NGSX."

Who are some of NeurogesX's key competitors?

Has NeurogesX been receiving favorable news coverage?

News coverage about NGSX stock has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. NeurogesX earned a daily sentiment score of 0.09 on Accern's scale. They also assigned media coverage about the specialty pharmaceutical company an impact score of 44.46 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of NeurogesX?

Shares of NGSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NeurogesX's stock price today?

One share of NGSX stock can currently be purchased for approximately $0.0050.

How big of a company is NeurogesX?

NeurogesX has a market capitalization of $129,628.00.

How can I contact NeurogesX?

NeurogesX's mailing address is 2215 Bridgepointe Pkwy Ste 200, FOSTER CITY, CA 94404-5067, United States. The specialty pharmaceutical company can be reached via phone at +1-650-3583300.


MarketBeat Community Rating for NeurogesX (NGSX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about NeurogesX and other stocks. Vote "Outperform" if you believe NGSX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGSX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NeurogesX (OTCMKTS:NGSX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/21/2016 forward)

Earnings

NeurogesX (OTCMKTS:NGSX) Earnings History and Estimates Chart

Earnings by Quarter for NeurogesX (OTCMKTS:NGSX)

NeurogesX (OTCMKTS NGSX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2012Q3 2012($0.18)($0.11)ViewN/AView Earnings Details
8/3/2012Q2 2012($0.20)($0.17)ViewN/AView Earnings Details
5/3/2012Q1 2012($0.29)($0.35)ViewN/AView Earnings Details
3/8/2012Q4 2011($0.41)($0.34)ViewN/AView Earnings Details
10/31/2011Q3 2011($0.44)($0.43)ViewN/AView Earnings Details
8/9/2011Q2 2011($0.71)($0.81)ViewN/AView Earnings Details
4/29/2011Q1 2011($0.68)($0.75)ViewN/AView Earnings Details
3/30/2011Q4 2010($0.69)($0.69)ViewN/AView Earnings Details
11/3/2010Q3 2010($0.65)($0.72)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.59)($0.58)ViewN/AView Earnings Details
5/11/2010Q1 2010($0.41)($0.52)ViewN/AView Earnings Details
3/18/2010Q4 2009($0.34)($0.29)ViewN/AView Earnings Details
11/6/2009Q3 2009($0.36)($0.38)ViewN/AView Earnings Details
8/7/2009Q2 2009($0.28)($0.31)ViewN/AView Earnings Details
5/7/2009Q1 2009($0.29)($0.26)ViewN/AView Earnings Details
3/20/2009Q4 2008($0.39)($0.27)ViewN/AView Earnings Details
11/6/2008Q3 2008($0.43)($0.36)ViewN/AView Earnings Details
8/13/2008Q2 2008($0.52)($0.40)ViewN/AView Earnings Details
5/15/2008Q1 2008($0.62)($0.46)ViewN/AView Earnings Details
3/26/2008Q4 2007($0.63)($0.58)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

NeurogesX (OTCMKTS:NGSX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

NeurogesX (OTCMKTS NGSX) Insider Trading and Institutional Ownership History

Insider Trading History for NeurogesX (OTCMKTS:NGSX)

NeurogesX (OTCMKTS NGSX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

NeurogesX (OTCMKTS NGSX) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

NeurogesX (OTCMKTS:NGSX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

NeurogesX (OTCMKTS:NGSX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

NeurogesX (OTCMKTS NGSX) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.